JPM 2022: Dexcom shows off new G7 data after submitting diabetes sensor for FDA review

Dexcom provided a look at new data for the upcoming generation of its continuous glucose monitoring sensor. Presenting at the J.P. Morgan Healthcare Conference, the details were pulled from a large clinical study as the company awaits the FDA’s blessing.

After enrolling more than 300 trial…